Aug 24 (Reuters) - Pharmaxis Ltd (PXS)
- Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis in debilitating liver disease nash
News: PXS Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
-0.001(3.33%) |
Mkt cap ! $34.62M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.7¢ | $92.11K | 3.218M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 129812 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 709078 | 2 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| SNT (ASX) Chart |